Daratumumab
Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells.
Product Specifications
CAS Number
945721-28-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
148 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-MP012929HU-01 10 µg
Recombinant Human Leukemia inhibitory factor receptor (LIFR), partial
Sign In for Pricing
View Details CSB-MP012929HU-02 50 µg
Recombinant Human Leukemia inhibitory factor receptor (LIFR), partial
Sign In for Pricing
View Details